As of November 6, 2026, Innospec Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 4, 2026 (Form 8-K, June 4, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Innospec Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Innospec Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-04. Every row below is cited to the filing it comes from, and this page adds each new change as Innospec Inc. files it.
Also on the record for Innospec Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 7, 2026 | Stake report, Schedule 13G, by Allspring Global Investments Holdings, LLC | 4.7% of the class | 5%+ stakes | Source |
| October 7, 2026 | Stake report, Schedule 13G/A, by Allspring Global Investments Holdings, LLC | 4.7% of the class | 5%+ stakes | Source |
| July 31, 2026 | Stake report, Schedule 13G/A, by Allspring Global Investments Holdings, LLC | 7.7% of the class | 5%+ stakes | Source |
| July 14, 2026 | Stake report, Schedule 13G, by Dimensional Fund Advisors LP | 5.3% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.22% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 7.51% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
Selling to them or working with them? See who runs Innospec Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Innospec Inc. and the records around it.
Innospec Inc. elsewhere on the record
Companies that share a holder
- Allspring Global Investments Holdings, LLC also filed stake reports on 49 other companies: abrdn Emerging Markets ex Chin (Oct 2026), AMC Global Media Inc (Oct 2026), EverQuote Inc (Oct 2026)
- Dimensional Fund Advisors LP also filed stake reports on 366 other companies: Acadia Healthcare Co Inc (Oct 2026), ADT Inc (Oct 2026), AGCO Corp (Oct 2026)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
Watch Innospec Inc.
Get an email when Innospec Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Innospec Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Innospec Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Innospec Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-04 | Reported | not named in the filing | 8-K, 2026-06-04 |
New leaders reset buying decisions — get the Full Report on Innospec Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Innospec Inc., with the record behind each one.
Find candidates like senior executive at Innospec Inc.Every change, in the filing's words
Reported
Ms. Bausch was also appointed to serve on the Company's Audit Committee as of July 1, 2026.
- Effective June 2, 2026, the Board of Directors ("Board") of Innospec Inc. (the "Company"), in accordance with the Amended and Restated By-Laws of the Company (i) increased the number of directors of the Company from seven (7) to eight (8), and (ii) appointed Shelley Bausch to serve as a Class II director of the Company starting as of July 1, 2026, and until the 2027 annual meeting of stockholders of the Company or until her successor is duly elected and qualified.
- Ms. Bausch will participate in the standard compensation plan for non-employee directors which includes an annual cash retainer of $100,000, paid quarterly and an additional annual retainer of $5,000, paid quarterly, for serving as an Audit Committee member.
- Ms. Bausch will also be eligible to receive an annual grant of equity under the Innospec Inc. Long-Term Incentive Omnibus Plan in February of each year, with an expected grant date value of $125,000 based on the closing price of the Company's stock on the date prior to the grant date.
- In February 2025, such awards were granted in the form of restricted stock units that vest in full three years after the grant date.
- As a non-employee director, she may also receive an additional daily fee of $2,000 for additional days provided at the specific request of the CEO.
Tools for this story
Each opens in a new tab, filled in for Innospec Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.